AARD
Aardvark Therapeutics, Inc. Common Stock
stockNASDAQ
At CloseNov 2, 2026 3:59:54 PM EST
1.21USD-10.741%(-0.14)338,485
Pre-marketNov 2, 2026 8:52:30 AM EST
1.33USD-1.481%(-0.02)
After-hoursNov 2, 2026 4:26:30 PM EST
1.201USD-0.332%(-0.004)
AARD Financials
In Q2 FY 2026 (ended ), Aardvark Therapeutics, Inc. Common Stock (AARD) reported revenue of $0, net income of −$14.39M, operating cash flow of −$17.6M, and assets of $81.46M.
Loading financial statements…